eMedicine Specialties > Ophthalmology > Cornea

Dystrophy, Granular: Follow-up

Author: William Trattler, MD, Miami Center for Excellence in Eye Care; Consulting Staff, Department of Ophthalmology, Miami Baptist Hospital
Coauthor(s): William Lloyd Clark, MD, Consulting Staff, Palmetto Retina; Natalie Afshari, MD, Assistant Professor, Cornea and Refractive Surgery, Department of Ophthalmology, Duke University Eye Center, Duke University Medical Center
Contributor Information and Disclosures

Updated: Mar 15, 2006

Follow-up

Further Outpatient Care

  • Patients with corneal epithelial defects from recurrent erosions need to be observed every few days to make certain the defect is healing.

Inpatient & Outpatient Medications

  • Patients with corneal epithelial defects from recurrent erosions require treatment with topical antibiotics to prevent infection.

Complications

  • Complications of granular corneal dystrophy include loss of vision and recurrent corneal erosions.
  • Complications of recurrent erosions include corneal infection and scarring, which can lead to significant decreased vision.

Prognosis

  • Prognosis is good, with symptomatic patients being eligible for either laser PTK or corneal transplant.

Miscellaneous

Special Concerns

  • A variant of granular dystrophy is called Avellino dystrophy. Its genetic defect also has been mapped to chromosome 5q.
    • In this condition, lattice deposits develop in the cornea years after typical granular deposits have developed. With age, deposits enlarge and form a corneal haze.
    • Symptoms are similar to granular dystrophy, with a slightly higher chance of pain and photophobia due to recurrent corneal erosions.
    • Management of Avellino dystrophy is similar to granular corneal dystrophy.
    • For excessive recurrent corneal erosions or decreased vision in eyes with predominantly superficial corneal opacities, excimer laser PTK can be performed.
    • For patients with vision loss after unsuccessful PTK, a corneal transplant can be performed. However, deposits eventually recur in the donor cornea.
  • Children of patients with granular corneal dystrophy should be monitored once they reach puberty, because this condition has an autosomal dominant inheritance pattern.
 


More on Dystrophy, Granular

Overview: Dystrophy, Granular
Differential Diagnoses & Workup: Dystrophy, Granular
Treatment & Medication: Dystrophy, Granular
Follow-up: Dystrophy, Granular
Multimedia: Dystrophy, Granular
References

References

  1. Albert D, Jakobiec F. Principles and Practice of Ophthalmology. Vol 1. 1994:26-49.

  2. Das S, Langenbucher A, Seitz B. Excimer laser phototherapeutic keratectomy for granular and lattice corneal dystrophy: a comparative study. J Refract Surg. Nov-Dec 2005;21(6):727-31. [Medline].

  3. Grunauer-Kloevekorn C, Brautigam S, Wolter-Roessler M. Molecular genetic analysis of the BIGH3 gene in lattice type I (Biber-Haab-Dimmer) and granular type II (Avellino) corneal dystrophy: is indirect mutation analysis for hot spots recommended?. Klin Monatsbl Augenheilkd. Dec 2005;222(12):1017-23. [Medline].

  4. Klintworth GK. Advances in the molecular genetics of corneal dystrophies. Am J Ophthalmol. Dec 1999;128(6):747-54. [Medline].

  5. Krachmer J. Cornea. Vol 2. 1996.

  6. Yamamoto S, Okada M, Tsujikawa M, et al. The spectrum of beta ig-h3 gene mutations in Japanese patients with corneal dystrophy. Cornea. May 2000;19(3 Suppl):S21-3. [Medline].

Further Reading

Keywords

granular dystrophy, corneal dystrophy, granular corneal dystrophy

Contributor Information and Disclosures

Author

William Trattler, MD, Miami Center for Excellence in Eye Care; Consulting Staff, Department of Ophthalmology, Miami Baptist Hospital
William Trattler, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Coauthor(s)

William Lloyd Clark, MD, Consulting Staff, Palmetto Retina
William Lloyd Clark, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Natalie Afshari, MD, Assistant Professor, Cornea and Refractive Surgery, Department of Ophthalmology, Duke University Eye Center, Duke University Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Fernando H Murillo-Lopez, MD, Senior Surgeon, Unidad Privada de Oftalmologia CEMES
Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital
Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Eye Bank Association of America, Pennsylvania Medical Society, and Philadelphia County Medical Society
Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.